Écrit par CGS | 25 Février 2015

Today’s vote in the UK House of Lords means that variations of embryonic genetic modification may soon be used in fertility clinics without any required follow-up of resulting children, despite extensive scientific, ethical, and legal objections heard from around the world. The UK is now the only country in the world to allow human germline modification, genetic changes that will be...

Écrit par CICR | 25 Février 2015

Bagdad / Genève (CICR) – La récente extension du conflit en Irak touche un nombre toujours plus grand de personnes, qui se comptent par centaines de milliers. Les provinces d'Anbar, de Ninive, de Salaheddine, de Diyala, et de Kirkouk ont été en butte à des attaques importantes, ce qui a contraint toujours plus de personnes à abandonner leurs maisons pour trouver refuge dans des zones...

Écrit par WHO | 25 Février 2015

24 February 2015, Freetown - Today, the World Health Organization's Regional Director for Africa, Dr Matshidiso Moeti, wraps up her visit to Sierra Leone, her first to an Ebola affected country.


The 3-day visit, which started on Saturday 21st February 2015, was aimed at gaining a better understanding of the ongoing situation, what progress has been made so far and which areas WHO could...

Écrit par GBI Research | 25 Février 2015

NEW YORK (GBI Research), 24 February 2015 - While drug candidates for Alzheimer’s Disease (AD) fail at a much higher rate than the pharmaceutical industry average, the total number of active drugs in the AD treatment pipeline is relatively large at 583, implying a high level of commercial interest, says business intelligence provider GBI Research.

The company’s latest report* states...